Get the Stockscreener App
0.00
100.00%
-0.2012
Essa Pharma Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
See More
Previous Close:
$0.2012
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$9.52M
Revenue:
-
Net Income/Loss:
$-28.54M
P/E Ratio:
0.00
EPS:
-0.64
Net Cash Flow:
$-22.72M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$5.75
Essa Pharma Inc Stock (EPIX) Company Profile
Name
Essa Pharma Inc
Sector
Industry
Phone
(778) 331-0962
Address
SUITE 720, VANCOUVER, BC
Compare EPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
0.00 | 9.52M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
418.63 | 107.73B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.02 | 62.04B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
482.85 | 62.73B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
829.86 | 51.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.62 | 34.67B | 398.11M | -1.03B | -868.57M | -5.7032 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-04-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-04-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-26-23 | Resumed | Oppenheimer | Outperform |
| Mar-04-21 | Initiated | Piper Sandler | Overweight |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Nov-02-20 | Initiated | Jefferies | Buy |
| Oct-25-19 | Initiated | Oppenheimer | Outperform |
View All
Essa Pharma Inc Stock (EPIX) Latest News
Can ESSA Pharma Inc. stock sustain institutional interestJuly 2025 EndofMonth & Verified Technical Signals - newser.com
What does recent volatility data suggest for ESSA Pharma Inc.Weekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Sector ETF performance correlation with ESSA Pharma Inc.Index Update & AI Driven Stock Reports - newser.com
Will ESSA Pharma Inc. stock outperform value stocksJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com
Can ESSA Pharma Inc. stock reach $100 price targetTrade Performance Summary & Detailed Earnings Play Alerts - newser.com
Can ESSA Pharma Inc. stock resist market sell offsJuly 2025 Drop Watch & AI Powered Market Entry Strategies - newser.com
Tools to assess ESSA Pharma Inc.’s risk profileWeekly Market Report & Comprehensive Market Scan Reports - newser.com
Using data filters to optimize entry into ESSA Pharma Inc.Market Rally & Entry Point Confirmation Alerts - newser.com
Custom watchlist performance reports with ESSA Pharma Inc.2025 Momentum Check & Technical Pattern Recognition Alerts - newser.com
Does ESSA Pharma Inc. fit your quant trading modelInflation Watch & Consistent Return Investment Signals - newser.com
How ESSA Pharma Inc. stock trades before earningsProfit Target & Community Consensus Trade Alerts - newser.com
Essa Pharma Inc Stock (EPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.96%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):